Lipocine Inc. (LPCN)
NASDAQ$3.68
Market Cap
$19.69M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
688 of 924
Rank in Industry
391 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
LPCN Insider Trading Activity
LPCN Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
No records found
About Lipocine Inc.
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that has completed Phase II clinical trial for the treatment of non-cirrhotic …
Insider Activity of Lipocine Inc.
Over the last 12 months, insiders at Lipocine Inc. have bought $0 and sold $0 worth of Lipocine Inc. stock.
On average, over the past 5 years, insiders at Lipocine Inc. have bought $88,871 and sold $135,851 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 8,706 shares for transaction amount of $43,791 was made by Patel Mahesh V. (CEO and President) on 2023‑05‑25.
List of Insider Buy and Sell Transactions, Lipocine Inc.
| 2023-05-25 | Patel Mahesh V. | CEO and President | 8,706 0.1614% | $5.03 | $43,791 | -23.22% | ||
| 2023-03-24 | Patel Mahesh V. | CEO and President | 150,000 0.0107% | $0.32 | $48,000 | -21.29% | ||
| 2023-03-20 | Ono Richard Dana | director | 4,000 0.0003% | $0.34 | $1,360 | -28.03% | ||
| 2023-03-17 | Patel Mahesh V. | CEO and President | 50,000 0.0032% | $0.33 | $16,500 | -32.85% | ||
| 2022-11-22 | Papapetropoulos Spyros | director | 21,739 0.0015% | $0.47 | $10,217 | -37.21% | ||
| 2022-11-14 | Patel Mahesh V. | CEO and President | 75,000 0.0051% | $0.39 | $29,250 | -23.07% | ||
| 2022-09-27 | Patel Mahesh V. | CEO and President | 100,000 0.0069% | $0.41 | $41,000 | -19.07% | ||
| 2022-05-17 | Fogarty Krista | Principal Accounting Officer | 12,500 0.0008% | $0.86 | $10,750 | -48.85% | ||
| 2022-05-16 | Patel Mahesh V. | CEO and President | 50,000 0.0032% | $0.77 | $38,495 | -39.61% | ||
| 2021-11-18 | Patel Mahesh V. | CEO and President | 25,000 0.0017% | $1.09 | $27,250 | -21.10% | ||
| 2020-12-31 | Sale | Higuchi John W. | director | 6,700 0.0005% | $1.35 | $9,054 | -0.74% | |
| 2020-12-16 | Sale | Patel Mahesh V. | Chief Executive Officer | 15,000 0.0013% | $1.35 | $20,250 | -1.45% | |
| 2020-12-16 | Sale | BROWN MORGAN R | EVP and CFO | 8,437 0.0007% | $1.35 | $11,390 | -1.45% | |
| 2020-12-04 | Sale | Patel Mahesh V. | Chief Executive Officer | 43,500 0.004% | $1.57 | $68,134 | -11.04% | |
| 2020-12-04 | Sale | BROWN MORGAN R | Chief Financial Officer | 17,250 0.0016% | $1.57 | $27,024 | -11.04% | |
| 2020-03-17 | Higuchi John W. | director | 220,000 0.0309% | $0.32 | $69,542 | +337.50% | ||
| 2019-12-31 | Patel Mahesh V. | CEO and President | 40,000 0.0057% | $0.38 | $15,340 | +214.05% | ||
| 2019-12-10 | Patel Mahesh V. | President and CEO | 25,000 0.0036% | $0.40 | $9,975 | +143.58% | ||
| 2019-12-04 | Sale | Patel Mahesh V. | CEO and President | 43,500 0.0061% | $0.41 | $17,835 | +124.07% | |
| 2019-12-04 | Sale | BROWN MORGAN R | EVP and Chief Financial Office | 17,250 0.0024% | $0.41 | $7,076 | +124.07% |
Total: 36
Insider Historical Profitability
43.52%
| Higuchi John W. | director | 693548 12.9626% | $2.55M | 2 | 1 | +337.5% |
| Patel Mahesh V. | CEO and President | 107418 2.0077% | $395,298.24 | 16 | 4 | +40.01% |
| Papapetropoulos Spyros | director | 21739 0.4063% | $79,999.52 | 1 | 0 | <0.0001% |
| Ono Richard Dana | director | 14125 0.264% | $51,980.00 | 2 | 1 | +6.64% |
| Fogarty Krista | Principal Accounting Officer | 12500 0.2336% | $46,000.00 | 1 | 0 | <0.0001% |
Historical Insider Profitability vs. Competitors
$992,222,850 | 90 | -12.52% | $19.15M | |
$6,204,522 | 45 | 1.91% | $20.18M | |
$550,024 | 37 | -2.68% | $20.87M | |
$85,897,100 | 36 | 2.47% | $17.87M | |
$1,363,112 | 33 | 15.03% | $22.22M |
LPCN Institutional Investors: Active Positions
| Increased Positions | 5 | +25% | 6,219 | +1.14% |
| Decreased Positions | 6 | -30% | 64,072 | -11.77% |
| New Positions | <1 | New | 65 | New |
| Sold Out Positions | 2 | Sold Out | 133 | Sold Out |
| Total Postitions | 19 | -5% | 486,671 | -10.62% |
LPCN Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $742.00 | 4.43% | 221,459 | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $299.00 | 1.79% | 89,272 | 0 | 0% | 2024-12-31 |
| Geode Capital Management, Llc | $193.00 | 1.15% | 57,464 | +3,248 | +5.99% | 2024-12-31 |
| Renaissance Technologies Llc | $121.00 | 0.72% | 36,032 | -4,300 | -10.66% | 2024-12-31 |
| Susquehanna International Group, Llp | $84.00 | 0.5% | 25,005 | -3 | -0.01% | 2024-12-31 |
| Dimensional Fund Advisors Lp | $69.00 | 0.41% | 20,516 | +2,500 | +13.88% | 2024-12-31 |
| State Street Corp | $62.00 | 0.37% | 18,626 | 0 | 0% | 2024-12-31 |
| Northern Trust Corp | $44.00 | 0.26% | 13,160 | 0 | 0% | 2024-12-31 |
| Morgan Stanley | $9.00 | 0.05% | 2,634 | 0 | 0% | 2024-12-31 |
| Tower Research Capital Llc (Trc) | $5.00 | 0.03% | 1,466 | +400 | +37.52% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.